Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Ataluren voor Duchenne voorwaardelijk in basispakket
nov 2021 | Neuro-musculair